4//SEC Filing
Carter Todd Alfred 4
Accession 0001104659-25-003772
CIK 0001640266other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:17 PM ET
Size
5.2 KB
Accession
0001104659-25-003772
Insider Transaction Report
Form 4
Carter Todd Alfred
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-01-14$5.13/sh−1,191$6,110→ 86,436 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.05 to $5.30, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001944011
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 4:17 PM ET
- Size
- 5.2 KB